Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31186268 | 1.00 | KDM4E (0.34) | KDM4EPKM | |
| SCHEMBL556904 | 0.79 | KDM4E (0.36) | KDM4EPKM | |
| SCHEMBL5701610 | 0.79 | KDM4E (0.36) | KDM4EPKM | |
| SCHEMBL28499627 | 0.76 | KDM4E (0.38) | KDM4EPKM | |
| SCHEMBL7064134 | 0.76 | KDM4E (0.34) | KDM4EPKM | |
| SCHEMBL5159548 | 0.76 | KDM4E (0.34) | KDM4EPKM | |
| SCHEMBL3860686 | 0.76 | CA1 (0.31) | — | |
| SCHEMBL6544873 | 0.74 | ADAMTS4 (0.31) | — | |
| SCHEMBL8817458 | 0.74 | KDM4E (0.37) | KDM4EPKM | |
| SCHEMBL8205643 | 0.74 | KDM4E (0.37) | KDM4EPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118894886-A | Preparation method of axial chiral alkenyl borate containing phosphine or carboxylate | 福州大学 | 2024-11-05 | — | — | CN | disclosed |
| EP-4325210-A1 | COMPOSITION, STABILIZATION METHOD, METHOD FOR MEASURING AMOUNT OF LUMINESCENCE, AND STABILIZER FOR LUMINESCENT SUBSTRATE | FUJIFILM Corporation (JP) | 2024-02-21 | — | — | EP | disclosed |
| US-20240043742-A1 | COMPOSITION, STABILIZATION METHOD, METHOD FOR MEASURING AMOUNT OF LUMINESCENCE, AND STABILIZER FOR LUMINESCENT SUBSTRATE | FUJIFILM CORPORATION (JP) | 2024-02-08 | — | — | US | disclosed |
| CN-112430234-B | Novel KRAS G12C protein inhibitor and preparation method and application thereof | 信达生物制药(苏州)有限公司 | 2023-04-28 | — | — | CN | disclosed |
| WO-2022220288-A1 | COMPOSITION, STABILIZATION METHOD, METHOD FOR MEASURING AMOUNT OF LUMINESCENCE, AND STABILIZER FOR LUMINESCENT SUBSTRATE | 富士フイルム株式会社 | 2022-10-20 | — | — | WO | disclosed |
| EP-3366750-B1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2021-07-21 | — | — | EP | disclosed |
| US-10961185-B2 | Stabilizer and stabilization method | FUJIFILM WAKO PURE CHEMICAL CHEMICAL CORPORATION (JP) | 2021-03-30 | — | — | US | disclosed |
| CN-112430234-A | Novel KRAS G12C protein inhibitor and preparation method and application thereof | 信达生物制药(苏州)有限公司 | 2021-03-02 | — | — | CN | disclosed |
| CN-108138047-B | Stabilizer and stabilization method | 富士胶片和光纯药株式会社 | 2021-02-09 | — | — | CN | disclosed |
| WO-2020184625-A1 | GRAPHENE NANORIBBON AND METHOD FOR PRODUCING SAME | 国立大学法人東海国立大学機構 | 2020-09-17 | — | — | WO | disclosed |
| CN-110452167-B | Quinoline derivatives, preparation method and application thereof | 东莞市东阳光农药研发有限公司 | 2020-08-21 | — | — | CN | disclosed |
| CN-110452167-A | Quinoline derivatives and its preparation method and application | DONGGUAN HEC PESTICIDE RES AND DEVELOPMENT CO LTD | 2019-11-15 | — | — | CN | disclosed |
| CN-109081310-A | A method of extracting bromine from brominated feed liquid or waste water | 山东省海洋化工科学研究院 | 2018-12-25 | — | — | CN | disclosed |
| US-20180290969-A1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM WAKO PURE CHEMICAL CHEMICAL CORPORATION (JP) | 2018-10-11 | — | — | US | disclosed |
| EP-3366750-A1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM Wako Pure Chemical Corporation (JP) | 2018-08-29 | — | — | EP | disclosed |
| CN-108138047-A | STABILIZER AND STABILIZATION METHOD | 和光纯药工业株式会社 | 2018-06-08 | — | — | CN | disclosed |
| US-9309174-B2 | Polycyclic ring assembly compound and organic electroluminescent device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-04-12 | — | — | US | disclosed |
| US-20100187512-A1 | POLYCYCLIC RING ASSEMBLY COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD (JP) | 2010-07-29 | — | — | US | disclosed |
| US-7109225-B2 | Antidiabetic agents; hypotensive agents; anticholesterol agents; antilipemic agents; antiinflammatory agents; antiproliferative agents | HOFMANN-LA ROCHE INC. (US) | 2006-09-19 | — | — | US | disclosed |
| US-20040157898-A1 | Novel substituted oxazole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180290969-A1 | STABILIZER AND STABILIZATION METHOD | H1-0, H1-2, H1-4 | KDM4E 1253/4885PKM 2289/4885 |
| US-20040157898-A1 | Novel substituted oxazole derivatives | OXA1L, SLC5A1, GPR119 | KDM4E 2839/4885PKM 1209/4885 |
| US-10961185-B2 | Stabilizer and stabilization method | H1-0, H1-2, H1-4 | KDM4E 1253/4885PKM 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.